CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a leader in life science research, today announced the introduction of two new instruments to complement technologies in its BioDiscovery business segment. The iBlot™ Dry Blotting system transfers proteins from polyacrylamide gels to nitrocellulose membranes in preparation for downstream analysis, while the iPrep™ purification instrument automates nucleic acid purification using Invitrogen’s ChargeSwitch™ technology.
